SVFC Stock News China Wireless Comms (SVFC) 0.0016 07/25/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
China Wireless Comms (SVFC) 0.0016 $SVFC

IntelliCell BioSciences Announces That Dr. Steven Victor Was Thanked for His Work in Brain Trauma Research for Veterans
Marketwire - Thu Mar 27, 8:01AM CDT
IntelliCell BioSciences, Inc. ("IntelliCell" or the "Company" (OTCQB: SVFC), a regenerative medicine company utilizing adult autologous vascular cells (SVCs) derived from the blood vessels found in adipose tissue, announced today that at the Stand For The Troops event in Washington, D.C. last Saturday, March 23, Major General John Batiste, US Army (Ret.) and Major Ben Richards, US Army (Ret.) the brain trauma veteran who received his purple heart, thanked our CEO, Steven Victor, MD for his help with brain trauma veterans.

IntelliCell BioSciences Announces That It Will Develop Investigational Clinical Protocol Studies for the Treatment of ALS With Dr. Manuel Trujillo
Marketwire - Mon Mar 24, 12:17PM CDT
IntelliCell BioSciences, Inc. ("IntelliCell" or the "Company" (OTCQB: SVFC), a regenerative medicine company utilizing adult autologous vascular cells (SVCs) derived from the blood vessels found in adipose tissue, announced today that it will be entering into a research collaboration with Dr. Manuel Trujillo, Clinical Psychiatry NYU Department of Psychiatry and Medical Director of the Amen Clinic, to use its unique approach to the harvest and use of autologous adipose derived stromal vascular fraction cells (SVFC) for clinical studies of ALS (Lou Gehrig's Disease).

IntelliCell BioSciences Announces It Will File an IND for Osteoarthritis of the Knee in Conjunction With the Andrews's Research and Educational Foundation
Marketwire - Mon Mar 17, 8:25AM CDT
IntelliCell Biosciences, Inc. ("IntelliCell" or the "Company" (OTCQB: SVFC), a regenerative medicine company utilizing adult autologous vascular cells (SVCs) derived from the blood vessels found in adipose tissue, announced today that it has signed consulting agreements with Dr Adam Anz and Dr Josh Hackel of the Andrews's Research and Education Foundation (AREF) in Gulf Breeze, Florida. Intellicell will be filing an IND for the treatment of osteoarthritis of knee lead by Dr. James Andrews and conducted by Drs. Anz and Hackel for its Stromal Vascular Fraction Cells (SVFC).

IntelliCell BioSciences Joins Forces With Dr. James Andrews's Research and Educational Foundation
Marketwire - Wed Mar 12, 1:36PM CDT
IntelliCell Biosciences, Inc. ("IntelliCell" or the "Company" (OTCQB: SVFC), a regenerative medicine company utilizing adult autologous vascular cells (SVCs) derived from the blood vessels found in adipose tissue, announced today that it has signed a license agreement with Dr. James Andrews's Research and Education Foundation (AREF) in Gulf Breeze, Florida for the installation of its cGTP Cellular Processing Lab for the manufacturing of Stromal Vascular Fraction Cells (SVFC).

IntelliCell BioSciences Raises Capital for Strategic Growth
Marketwire - Wed Mar 12, 12:59PM CDT
IntelliCell BioSciences, Inc. ("IntelliCell" or the "Company" (OTCQB: SVFC), a regenerative medicine company utilizing adult autologous vascular cells (SVFCs) derived from the blood vessels found in adipose tissue, announced today that it has closed on a round of financing from Yorkville Advisors, LLC.

Global Vending Machine Market 2014-2018
PR Newswire - Wed Jan 22, 9:29AM CST
Reportlinker.com announces that a new market research report is available in its catalogue:

IntelliCell Biosciences Announces it Has Received Notification That International Patents for Canada, Europe and Korea Are Filed and Pending Approvals
ACCESSWIRE - Thu Sep 19, 1:05PM CDT
NEW YORK, NY, September 19, 2013 - (ACCESSWIRE)- IntelliCell Biosciences, Inc. ("Company" (OTC Pink: SVFC) announced today that it has received notification that the Canadian Application, No. 2823123, Entitled: ULTRASONIC CAVITATION DERIVED STROMAL OR MESENCHYMAL VASCULAR EXTRACTS AND CELLS DERIVED THEREFROM OBTAINED FROM ADIPOSE TISSUE AND USED THEREOF has been filed.

OTC Signal Daily Stock Watch - IntelliCell BioSciences (OTC:SVFC)
WorldStockWire - Sun Sep 08, 8:30PM CDT
OTC Signal tracks stocks daily and is pleased to offer its stock alerts. Investors can receive FREE Stock Alerts and company news and profiles by visiting OTC Signal at the following: http://www.otcsignal.com

IntelliCell BioSciences Discusses their Stem Cell Treatment Technology in Online Interview
ACCESSWIRE - Fri Jul 12, 11:32AM CDT
NEW YORK, NY, July 12, 2013 - (eTeligis via ACCESSWIRE) IntelliCell BioSciences, Inc. (OTC PINK: SVFC), a developer of novel, patented stromal vascular fraction cells (stem cells) technologies that address the regenerative, curative and preventative conditions of disease states, announces an online interview where they discuss their current SVF (stem cell) treatment technology.

Maxim Group Issues Stem Cell Sector Report on IntelliCell BioSciences Based on Treatment Process
ACCESSWIRE - Mon Jul 08, 12:01PM CDT
NEW YORK, July 08, 2013 (eTeligis via ACCESSWIRE) -- IntelliCell BioSciences, Inc. (OTCPINK: SVFC), a developer of novel, patented technology used to isolate stromal vascular fraction cells (stem cells) from adipose (fat) tissue. These cells are used to address the regenerative, curative and preventative conditions of disease, announced New York based Maxim Group has issued a research opinion on stem cell sector, and our position within the industry.

IntelliCell BioSciences Announces That Dr Zain Khalpey Has Joined Its Advisory Board
ACCESSWIRE - Mon Jun 17, 10:41AM CDT
NEW YORK, NY June 17, 2013 / -- IntelliCell BioSciences, Inc. ("Company" (OTC PINK: SVFC) announced today that Dr Zain Khalpey, MD, PhD, MRCS (Eng) Director, Heart Transplant Program & Mechanical Circulatory Support, Division of Cardiothoracic Surgery?Associate Professor of Surgery, Physiological Sciences & Biomedical Engineering, University of Arizona College of Medicine has joined the Advisory Board.

IntelliCell BioSciences Announces That Its Cellular Tissue Laboratory was inspected by FDA
PR Newswire - Fri Jun 14, 11:40AM CDT
IntelliCell BioSciences, Inc. ("Company" (OTC Pink: SVFC) announced today that on May 14, 2013 through June 2, 2013, its cellular laboratory facility underwent a thorough inspection by the FDA. The observations from the FDA inspection were provided to the company in the Form 483. The Company will respond to those observations in a timely manner. IntelliCell will take the necessary actions to address the relevant FDA observations.

IntelliCell BioSciences Receives US Patent for its Stem Cell Extraction Technology
PR Newswire - Thu Jun 13, 11:53AM CDT
IntelliCell BioSciences, Inc. ("Company" (SVFC) announces that it has been notified by the US Patent office that its patent for stem cell extraction technology has been published. IntelliCell's proprietary patented method for deriving blood vessel originated vascular cells from adipose (fat) tissue by use of ultrasonic cavitation has been made official. This technology involves an innovative mechanical method for the separation of stromal vascular fraction cells from adipose (fat) tissue, without the use of enzymes. Vascular cells derived by IntelliCell's proprietary method are potentially useful in bringing the promise of regenerative medicine to many therapeutic and aesthetic procedures. Investors can access the published patent at the US Patent website by entering the patent # 8,440,440. Link to patent website: http://patft.uspto.gov/netahtml/PTO/srchnum.htm
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Lymphatic Research Gains Attention Beyond Wellness Claims

Updated Category News Views 468

Ankles leave little clues after a long day: sock grooves, puffiness, that dull heaviness nobody bothers to name. PureHealth Research wants people to look past the usual salt-and-water explanation and consider the lymphatic system, the body’s comparatively unsung network for gathering fluid from tissues and returning it to the bloodstream. Fair enough. This system does...

Continue Reading
Newegg’s GIGABYTE Event Is Brand Work, Not a Catalyst

Updated Category News Views 514

A 2,300-square-foot room can tell a retailer plenty about its tribe. On November 21, Newegg is turning its Diamond Bar Gamer Zone into the home base for GIGABYTE’s AORUS VS40 celebration, a free five-hour event marking the hardware maker’s 40th anniversary. There will be 1v1 VALORANT and League of Legends contests, demo stations, raffles, anniversary merchandise, food...

Continue Reading
Mission Inn’s Lights Enter a Tender New Ownership Era

Updated Category News Views 527

A holiday spectacle can outlive the hands that hung its first bulb. Riverside is about to test that truth in public, under millions of tiny lights and the very large shadow of a family departure. The Mission Inn Festival of Lights returns in 2026 without Kelly and Duane Roberts as hotel owners for the first time in more than three decades. Duane Roberts died in 2025, the...

Continue Reading
3TREES Tests a Bigger Asia-Pacific Growth Blueprint

Updated Category News Views 350

A bucket of paint rarely sounds strategic until it sits inside a regional supply chain. That is the useful part of 3TREES chairman and president Hong Jie's message from the Asia-Pacific Economic Cooperation CEO Summit in Shenzhen on November 17-18, 2026: coatings are not merely a commodity if the supplier can bring materials, energy savings, technical know-how and...

Continue Reading
D-Wave Investors Face a December 15 Lead Plaintiff Clock

Updated Category News Views 479

August Put the Story Under a Harsh Light Two ugly August trading sessions are doing a lot of work in the case now confronting D-Wave Quantum. The company sits in a field that attracts big dreams, big headlines, and, frankly, plenty of investor imagination. But imagination does not cushion a portfolio when expectations crack. The lawsuits concern people who bought or...

Continue Reading
Sitting, Lymph Flow, and a Supplement Maker's Pitch

Updated Category News Views 292

By late afternoon, a chair can feel like it has quietly won the argument against your legs. PureHealth Research is leaning into that familiar heavy, puffy-legged feeling with a reminder about lymphatic flow—and, naturally, an eight-ingredient supplement positioned alongside it. The broad message is sensible. The sales layer needs the usual healthy squint. Movement Does...

Continue Reading
ModuleMD Takes Allergy EHR AI Beyond the Usual Hype Cycle

Updated Category News Views 354

Allergy Workflows Are Where This Has to Earn Its Keep Allergy clinics do not need another shiny dashboard clogging up a workstation. They need less typing, fewer handoffs, cleaner documentation, and fewer administrative chores slipping through the cracks while a packed day keeps moving. That is the practical lens for ModuleMD's ACAAI 2026 presentation in Phoenix: not...

Continue Reading
Isar’s Nova Scotia Pad Build Gives MAXQ a Real Test

Updated Category News Views 631

Concrete work is where space ambition stops being a brochure. Isar Aerospace has taken operational responsibility for its dedicated launch infrastructure at Spaceport Nova Scotia, and construction is beginning on the Canadian launch pad it will use. For Maritime Launch Services, this is the sort of update that deserves more than the usual starry-eyed applause. A Site...

Continue Reading
CARsgen's CT1182 Data Opens a Careful New CAR-T Test

Updated Category News Views 90

Six very sick lymphoma patients are not a victory lap, but they can still make the whole cell-therapy field sit up straighter. CARsgen has disclosed first clinical results for CT1182, an in vivo CAR-T candidate built on its CARvivo platform, and the early package is plainly more interesting than the usual preclinical chest-thumping. The company reported three complete...

Continue Reading
FASTEN Data Offers an Early Look at Ladera Closure

Updated Category News Views 122

Femoral access may be the unglamorous part of a valve procedure, but it is where an otherwise tidy case can turn ugly in a hurry. That makes Ladera Medical's full FASTEN data worth a careful look. The company reported results in 55 patients undergoing transfemoral TAVR/TAVI, and the numbers presented at London Valves 2026 suggest its large-bore closure system may address...

Continue Reading

Top 5 Most Recently Viewed Articles

Aspen Snowmass Summer 2026: New Experiences Beckon

Updated Category News Views 20

Summer Thrills: Aspen Snowmass Expands its Horizon Forget what you thought you knew about Aspen Snowmass—summer 2026 is flipping the script. With a fresh lineup of activities and enhancements, they’re not just boosting the excitement—they’re rewriting the summer playbook. Let’s dive straight into the offerings that are going to keep this mountain town buzzing...

Continue Reading
Navigating the Coming Interest Rate Cuts: Strategies for You

Updated Category News Views 58

Understanding Potential Interest Rate Cuts The Federal Reserve is poised to lower interest rates, which could present advantageous opportunities for both borrowers and savers. Fed Chair Jerome Powell has indicated that these cuts may happen soon, leading analysts to forecast that the first reduction could occur during the Fed's upcoming meeting. Additionally, further...

Continue Reading
Continuum Powders and INDO-MIM Innovate with Ni718 Production

Updated Category News Views 169

Innovative Milestone in 3D Printing Technologies Continuum Powders has made a significant impact in the additive manufacturing sector by announcing successful qualifications of their OptiPowder Ni718 alloy in collaboration with INDO-MIM Inc. Unlocking New Production Capabilities INDO-MIM Inc, a leading U.S.-based service provider in precision manufacturing, has qualified...

Continue Reading
Oracle Corp. Q2 Earnings Review and Analyst Outlook Changes

Updated Category News Views 187

Oracle Corp's Recent Q2 Earnings Review Oracle Corp. (NYSE: ORCL) recently released its financial results for the second quarter of fiscal 2026, presenting a mixed bag that has garnered mixed reactions from industry analysts. Financial Highlights and Performance Analysis The company reported a revenue of $16.06 billion, which fell short of analysts' expectations set at...

Continue Reading
Class 1 Nickel Reveals Ambitious Plans for Alexo-Dundonald Project

Updated Category News Views 98

Class 1 Nickel's Commitment to the Future In a recent update, Class 1 Nickel and Technologies Ltd. (CSE: NICO | OTCQB: NICLF) announced exciting plans aimed at advancing their Alexo-Dundonald Nickel Sulphide Project. Spanning approximately 3,093 hectares, this project is strategically situated in a prominent mining district. Progress Over the Years For the past two years,...

Continue Reading